Latest Updates

News, Stories & Healthcare Insights

News

July 8, 2026

The Value of Affordable Medicines

Affordable medicines are one of the most powerful tools for keeping healthcare systems sustainable. ♻️ 🌱 According to an IQVIA 2024 report, in Europe, affordable pharmaceuticals (so-called “generics”) account...

News

June 25, 2026

Apremilast 10mg, 20mg and 30mg tablets are now launched in Europe

We are proud to announce the launch of Apremilast 10 mg, 20 mg, and 30 mg tablets in Europe. 💊 Developed and manufactured in-house by Tiefenbacher Group, Apremilast is...

News, People

June 16, 2026

🌍From Hyderabad to Hamburg: Meet Sarithapriya👋

As part of our internal exchange program, Sarithapriya, Assistant Manager in our Regulatory Affairs team in Hyderabad, India, is currently spending three months in Hamburg, working closely with colleagues...

Innovation, News

June 11, 2026

#1 allergy medicines in German pharmacies🏆

#1 allergy medicines in German pharmacies🏆 According to the latest IQVIA market data, Bilastine-based allergy medicines developed and manufactured by Tiefenbacher Group are currently the most purchased allergy products...

News, People

May 28, 2026

Meet Marie, People & Culture Business Partner

What makes a workplace truly inspiring? For Marie-Theres Blumers, it is the people, the international collaboration, and the shared ambition to continuously move forward together. 🌍 As Business Partner...

News

May 26, 2026

Safinamide 50 mg & 100 mg successfully launched in the UK

Parkinson`s medication Safinamide 50 mg & 100 mg successfully launched in the UK 🚀 For patients living with Parkinson’s disease, continuity of treatment matters every day. In the UK...

Innovation, News

April 22, 2026

Earth Day 2026 – Sustainable Packaging

Today marks Earth Day🌍 – a reminder of the responsibility we carry to reduce our environmental impact across our operations. 🌱 At #TiefenbacherGroup, sustainability is part of how we...

Innovation, News

April 11, 2026

New High Potency Site in India

Innovation has always been part of our DNA 🧬 – but what drives us is people. 💙 At our new high-potency development and manufacturing site in Hyderabad, India, we...

News

October 24, 2025

Tiefenbacher Group at CPHI Frankfurt 2025

After weeks of preparation, the countdown is finally over. Next week, our Tiefenbacher Group team will be at CPHI in Frankfurt. Before we unveil our new booth design, take...

News

October 20, 2025

Celebrating the Spirit of Diwali at Tiefenbacher Laboratories

The festival of lights is certainly the right time to say thank you to our valued business friends and partners, and especially to our many dear colleagues in India...

Events

October 16, 2025

Reflections from AI in Pharma event in Basel

Our Head of Global Digitalization & AI, Sayan Sarkar, recently joined the AI in Pharma Project Management event by Why Summits? in Basel on stage and as panelist, sharing...

News

October 10, 2025

Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy ® (Tegomil Fumarate) in Germany

Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy® (Tegomil Fumarate) in GermanyAt Tiefenbacher Group, we are deeply committed to developing and delivering high-quality, value-added pharmaceuticals that improve the...